Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome

Autor: Davids, Matthew S. ^{*, *}, Rogers, Kerry A. ^*, Tyekucheva, Svitlana, Wang, Zixu, Pazienza, Samantha, Renner, Sarah K., Montegaard, Josie, Ihuoma, Udochukwu, Lehmberg, Timothy Z., Parry, Erin M., Wu, Catherine J., Jacobson, Caron A., Fisher, David C., Thompson, Philip A., Brown, Jennifer R.

Publikováno v: In Blood 3 February 2022 139(5):686-689

Functional Anti-Apoptotic Protein Dependence and Its Relation to Genomic Prognostic Markers and Response to Treatment in Chronic Lymphocytic Leukemia

Autor: Chong, Stephen Jun Fei, Lu, Junyan ^*, Valentin, Rebecca, Lehmberg, Timothy Z. ^*, Collins, Mary C ^*, Herbaux, Charles, Niemann, Carsten Utoft, Huber, Wolfgang ^*, Zenz, Thorsten, Davids, Matthew S.

Publikováno v: In Blood 15 November 2022 140 Supplement 1:4119-4120

The Fully Human Anti-CD47 Antibody SRF231 Has Dual-Mechanism Antitumor Activity Against Chronic Lymphocytic Leukemia (CLL) Cells and Increases the Activity of Both Rituximab and Venetoclax

Autor: Valentin, Rebecca, Peluso, Marisa O. ^*, Lehmberg, Timothy Z. ^*, Adam, Ammar ^*, Zhang, Li ^*, Armet, Caroline M. ^*, Guerriero, Jennifer L. ^*, Lee, Benjamin H., Palombella, Vito J., Holland, Pamela M. ^*, Paterson, Alison M. ^*, Davids, Matthew S.

Publikováno v: In Blood 29 November 2018 132 Supplement 1:4393-4393

A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia.

Autor: Gadi D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Griffith A; Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Tyekucheva S; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Wang Z; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Rai V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Vartanov A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Thrash E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Lehmberg TZ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lee B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Martindale SP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Machado JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Odejide O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Arnason J; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, USA., Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Lederer JA; Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. jennifer_brown@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. jennifer_brown@dfci.harvard.edu.

Publikováno v: Leukemia [Leukemia] 2022 Mar; Vol. 36 (3), pp. 723-732. Date of Electronic Publication: 2021 Nov 06.